BioProtonics is an MR-based diagnostic platform that develops new and sensitive diagnostic tools for ultra efficient operating model.
bioProtonics has raised $2.7M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2024.
bioProtonics's investors include National Science Foundation.
bioProtonics is headquartered in Santa Barbara, United States.
BioProtonics is an MR-based diagnostic platform that develops new and sensitive diagnostic tools for ultra efficient operating model.
bioProtonics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"bioProtonics — Funding & Investors." VCBacked, December 31, 2024, https://www.vcbacked.co/company/bioprotonics. Accessed August 7, 2026.
VCBacked. (2024). bioProtonics — Funding & Investors. Retrieved August 7, 2026, from https://www.vcbacked.co/company/bioprotonics
{{cite web |title=bioProtonics — Funding & Investors |url=https://www.vcbacked.co/company/bioprotonics |website=VCBacked |access-date=August 7, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated